228 related articles for article (PubMed ID: 9765515)
1. A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels.
Kuo CC
Mol Pharmacol; 1998 Oct; 54(4):712-21. PubMed ID: 9765515
[TBL] [Abstract][Full Text] [Related]
2. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones.
Kuo CC; Lu L
Br J Pharmacol; 1997 Jul; 121(6):1231-8. PubMed ID: 9249262
[TBL] [Abstract][Full Text] [Related]
3. The external pore loop interacts with S6 and S3-S4 linker in domain 4 to assume an essential role in gating control and anticonvulsant action in the Na(+) channel.
Yang YC; Hsieh JY; Kuo CC
J Gen Physiol; 2009 Aug; 134(2):95-113. PubMed ID: 19635852
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications.
Kuo CC; Chen RS; Lu L; Chen RC
Mol Pharmacol; 1997 Jun; 51(6):1077-83. PubMed ID: 9187275
[TBL] [Abstract][Full Text] [Related]
5. An inactivation stabilizer of the Na+ channel acts as an opportunistic pore blocker modulated by external Na+.
Yang YC; Kuo CC
J Gen Physiol; 2005 May; 125(5):465-81. PubMed ID: 15824190
[TBL] [Abstract][Full Text] [Related]
6. Lidocaine, carbamazepine, and imipramine have partially overlapping binding sites and additive inhibitory effect on neuronal Na+ channels.
Yang YC; Huang CS; Kuo CC
Anesthesiology; 2010 Jul; 113(1):160-74. PubMed ID: 20526191
[TBL] [Abstract][Full Text] [Related]
7. Properties of human brain sodium channel α-subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine.
Qiao X; Sun G; Clare JJ; Werkman TR; Wadman WJ
Br J Pharmacol; 2014 Feb; 171(4):1054-67. PubMed ID: 24283699
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells.
Lang DG; Wang CM; Cooper BR
J Pharmacol Exp Ther; 1993 Aug; 266(2):829-35. PubMed ID: 8394919
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker.
Yang YC; Kuo CC
Mol Pharmacol; 2002 Nov; 62(5):1228-37. PubMed ID: 12391287
[TBL] [Abstract][Full Text] [Related]
10. Network-specific mechanisms may explain the paradoxical effects of carbamazepine and phenytoin.
Thomas EA; Petrou S
Epilepsia; 2013 Jul; 54(7):1195-202. PubMed ID: 23566163
[TBL] [Abstract][Full Text] [Related]
11. Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.
Ragsdale DS; Scheuer T; Catterall WA
Mol Pharmacol; 1991 Nov; 40(5):756-65. PubMed ID: 1658608
[TBL] [Abstract][Full Text] [Related]
12. Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons.
Kuo CC; Bean BP
Mol Pharmacol; 1994 Oct; 46(4):716-25. PubMed ID: 7969051
[TBL] [Abstract][Full Text] [Related]
13. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
Catterall WA
Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
[TBL] [Abstract][Full Text] [Related]
15. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
Errington AC; Stöhr T; Heers C; Lees G
Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of the novel anticonvulsant SB-204269 on voltage-dependent currents in neurones cultured from rat hippocampus.
Caeser M; Evans ML; Benham CD
Neurosci Lett; 1999 Aug; 271(1):57-60. PubMed ID: 10471213
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity.
Farber NB; Jiang XP; Heinkel C; Nemmers B
Mol Psychiatry; 2002; 7(7):726-33. PubMed ID: 12192617
[TBL] [Abstract][Full Text] [Related]
18. Blockade of neuronal sodium channels by the antiepileptic drugs phenytoin, carbamazepine and sodium valproate.
Pugsley MK; Yu EJ; Mclean TH; Goldin AL
Proc West Pharmacol Soc; 1999; 42():105-8. PubMed ID: 10697707
[No Abstract] [Full Text] [Related]
19. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.
Ilyin VI; Hodges DD; Whittemore ER; Carter RB; Cai SX; Woodward RM
Br J Pharmacol; 2005 Mar; 144(6):801-12. PubMed ID: 15778702
[TBL] [Abstract][Full Text] [Related]
20. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
Sheets PL; Heers C; Stoehr T; Cummins TR
J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
